ABSTRACT

C - T D - F Available vaccines are active only against group C meningococci,

and not against group B which is almost as common in the UK E - F Penicillin is the treatment of choice. Resistance among meningo­

cocci is very rare in the UK

- T May be resistant to many other anti-staphylococcal antibiotics but is usually sensitive to vancomycin. Vancomycin resistance is now described in clinical strains from Japan and elsewhere

B - F Is no more likely to cause deep-seated infections than ordinary Staphylococcus aureus strains

C - T D - T Many patients and staff exposed to these may be colonised

asymptomatically in the nose, axillae and groins E - F May belong to one of several phage types. In fact, phage typing is

used to distinguish among strains of MRSA

3. A - F Act on ribosomes, so interfere with protein synthesis B - T C - F Have no activity against streptococci, including Streptococcus pneumoniae D - F Can be used with caution and close monitoring of blood levels E - F Toxicity is to the vestibular and cochlear branches of the eighth nerve

- T This is true of group A meningococcus, which is very uncommon in temperate countries. Group C and group B meningococci are more likely to be transmitted by close personal contact.